Lucid Diagnostics Inc. Cost of Revenue
Lucid Diagnostics Inc. (LUCD) reported Cost of Revenue of $1.45 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Expense Statement
us-gaap:CostOfRevenue · last filed 2026-08-12
- Lucid Diagnostics Inc. cost of revenue for the quarter ending 2026-06-30 was $1.45M, a 7.55% decline year-over-year.
- Lucid Diagnostics Inc. cost of revenue for the quarter ending 2026-03-31 was $1.63M, a 4.77% increase year-over-year.
- Lucid Diagnostics Inc. cost of revenue for the quarter ending 2025-06-30 was $1.56M.
- Lucid Diagnostics Inc. cost of revenue for the quarter ending 2025-03-31 was $1.55M.
- Lucid Diagnostics Inc. cost of revenue for fiscal 2025 was $6.67M, a 6.04% decline from fiscal 2024.
- Lucid Diagnostics Inc. cost of revenue for fiscal 2024 was $7.10M.
- Lucid Diagnostics Inc. cost of revenue for fiscal 2021 was $585.00K.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.45M 10-Q · filed 2026-08-12 | $3.07M 10-Q · filed 2026-08-12 | ||
| 2026-03-31 | $1.63M 10-Q · filed 2026-05-13 | |||
| 2025-12-31 | $6.67M 10-K · filed 2026-03-25 | |||
| 2025-06-30 | $1.56M 10-Q · filed 2026-08-12 | $3.11M 10-Q · filed 2026-08-12 | ||
| 2025-03-31 | $1.55M 10-Q · filed 2026-05-13 | |||
| 2024-12-31 | $7.10M 10-K · filed 2026-03-25 | |||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $369.00K 10-Q · filed 2022-08-15 | $809.73K derived: sum of 3 quarters · filed 2022-08-15 | $954.00K derived: sum of 4 quarters · filed 2022-08-15 |
| 2022-03-31 | $369.00K 10-Q · filed 2022-05-16 | $809.73K derived: sum of 2 quarters · filed 2022-05-16 | $954.00K derived: sum of 3 quarters · filed 2022-05-16 | |
| 2021-12-31 | $440.73K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-06 | $585.00K derived: sum of 2 quarters · filed 2022-04-06 | $585.00K 10-K · filed 2022-04-06 | |
| 2021-09-30 | $144.27K 10-Q · filed 2021-11-23 | $144.27K 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |